Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina

Vision Research

Volumn 44, Issue 4, 2004, Pages 349-356

  Gao, Hua ^a,c   Qiao, Xiaoxi ^b   Gao, Rui ^b   Mieler, William F ^a   McPherson, Alice R ^a   Holz, Eric R ^a  

^a CULLEN EYE INSTITUTE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Age related macular degeneration; Neovascularization; Triamcinolone; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; TRIAMCINOLONE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; IN SITU HYBRIDIZATION; NONHUMAN; NORTHERN BLOTTING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA; RETINA BIPOLAR GANGLION CELL; RETINA NERVE CELL; SUBRETINAL NEOVASCULARIZATION;

EID: 0344196834     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.visres.2003.09.027     Document Type: Article

References (47)

1. Adamis A.P., Miller J.W., Bernal M.T., D'Amico D.J., Folkman J., Yeo T.K., Yeo K.T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. American Journal of Ophthalmology. 118:1994;445-450.
2. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine. 331:1994;1480-1487.
3. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., Ferrara N., King G.L., Smith L.E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proceedings of the National Academy of Sciences of the United States of America. 92:1995;10457-10461.
4. Antoszyk A.N., Gottlieb J.L., Machemer R., Hatchell D.L. The effects of intravitreal triamcinolone acetonide on experimental pre- retinal neovascularization. Graefes Archive for Clinical and Experimental Ophthalmology. 231:1993;34-40.
5. Berkowitz B.A., Lukaszew R.A., Mullins C.M., Penn J.S. Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Investigative Ophthalmology & Visual Science. 39:1998;391-396.
6. Bucala R. Neuroimmunomodulation by macrophage migration inhibitory factor (MIF). Adolescent Gynecology and Endocrinology: Basic and Clinical Aspects. 840:1998;74-82.
7. Campochiaro P.A., Soloway P., Ryan S.J., Miller J.W. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Molecular Vision. 5:1999;34.
8. Challa J.K., Gillies M.C., Penfold P.L., Gyory J.F., Hunyor A.B., Billson F.A. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Australian and New Zealand Journal of Ophthalmology. 26:1998;277-281.
9. Ciulla T.A., Criswell M.H., Danis R.P., Hill T.E. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Archives of Ophthalmology. 119:2001;399-404.
10. Cui J.Z., Kimura H., Spee C., Thumann G., Hinton D.R., Ryan S.J. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefes Archive for Clinical and Experimental Ophthalmology. 238:2000;326-333.
11. Danis R.P., Bingaman D.P., Yang Y., Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology. 103:1996;2099-2104.
12. Danis R.P., Ciulla T.A., Pratt L.M., Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 20:2000;244-250.
13. Frank R.N. Growth factors in age-related macular degeneration: Pathogenic and therapeutic implications. Ophthalmic Research. 29:1997;341-353.
14. Frank R.N. Reply. Ophthalmic Research. 31:1999;245.
15. Frank R.N., Amin R.H., Eliott D., Puklin J.E., Abrams G.W. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. American Journal of Ophthalmology. 122:1996;393-403.
16. Gao H., Hollyfield J.G. Basic fibroblast growth factor in retinal development: Differential levels of bFGF expression and content in normal and retinal degeneration (rd) mutant mice. Developmental Biology. 169:1995;168-184.
17. Gao G., Li Y., Zhang D., Gee S., Crosson C., Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Letters. 489:2001;270-276.
18. Gao H., Qiao X., Hefti F., Hollyfield J.G., Knusel B. Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Investigative Ophthalmology & Visual Science. 38:1997;1840-1847.
19. Grossniklaus H.E., Ling J.X., Wallace T.M., Dithmar S., Lawson D.H., Cohen C., Elner V.M., Elner S.G., Sternberg P. Jr. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Molecular Vision. 8:2002;119-126.
20. Hasan Q., Tan S.T., Gush J., Peters S.G., Davis P.F. Steroid therapy of a proliferating hemangioma: Histochemical and molecular changes. Pediatrics. 105:2000;117-120.
21. Horiuchi T., Weller P.F. Expression of vascular endothelial growth factor by human eosinophils: Upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. American Journal of Respiratory Cell and Molecular Biology. 17:1997;70-77.
22. Hyder S.M., Huang J.C., Nawaz Z., Boettger-Tong H., Makela S., Chiappetta C., Stancel G.M. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environmental Health Perspectives. 108(Suppl. 5):2000;785-790.
23. Ishibashi T., Hata Y., Yoshikawa H., Nakagawa K., Sueishi K., Inomata H. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Archive for Clinical and Experimental Ophthalmology. 235:1997;159-167.
24. Itaya H., Imaizumi T., Yoshida H., Koyama M., Suzuki S., Satoh K. Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide. Thrombosis and Haemostasis. 85:2001;171-176.
25. Jonas J.B., Kreissig I., Hugger P., Sauder G., Panda-Jonas S., Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. British Journal of Ophthalmology. 87:2003;462-468.
26. Krzystolik M.G., Afshari M.A., Adamis A.P., Gaudreault J., Gragoudas E.S., Michaud N.A., Li W., Connolly E., O'Neill C.A., Miller J.W. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Archives of Ophthalmology. 120:2002;338-346.
27. Kwak N., Okamoto N., Wood J.M., Campochiaro P.A. VEGF is major stimulator in model of choroidal neovascularization. Investigative Ophthalmology & Visual Science. 41:2000;3158-3164.
28. Macular Photocoagulation Study Group Argon laser photocoagulation for neovascular maculopathy: Five-year results from randomized clinical trials. Archives of Ophthalmology. 109:1991;1109-1114.
29. Malecaze F., Clamens S., Simorre-Pinatel V., Mathis A., Chollet P., Favard C., Bayard F., Plouet J. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Archives of Ophthalmology. 112:1994;1476-1482.
30. McLaren J., Prentice A., Charnock-Jones D.S., Millican S.A., Muller K.H., Sharkey A.M., Smith S.K. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. Journal of Clinical Investigation. 98:1996;482-489.
31. Miller J.W., Adamis A.P., Shima D.T., D'Amore P.A., Moulton R.S., O'Reilly M.S., Folkman J., Dvorak H.F., Brown L.F., Berse B. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. American Journal of Pathology. 145:1994;574-584.
32. Nauck M., Karakiulakis G., Perruchoud A.P., Papakonstantinou E., Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. European Journal of Pharmacology. 341:1998;309-315.
33. Okamoto N., Tobe T., Hackett S.F., Ozaki H., Vinores M.A., LaRochelle W., Zack D.J., Campochiaro P.A. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. American Journal of Pathology. 151:1997;281-291.
34. Oue T., Taira Y., Shima H., Miyazaki E., Puri P. Effect of antenatal glucocorticoid administration on insulin-like growth factor I and II levels in hypoplastic lung in nitrofen-induced congenital diaphragmatic hernia in rats. Pediatric Surgery International. 15:1999;175-179.
35. Penfold P.L., Gyory J.F., Hunyor A.B., Billson F.A. Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Australian and New Zealand Journal of Ophthalmology. 23:1995;293-298.
36. Penfold P.L., Wen L., Madigan M.C., Gillies M.C., King N.J., Provis J.M. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: Implications for macular degeneration. Clinical and Experimental Immunology. 121:2000;458-465.
37. Penfold P.L., Wong J.G., Gyory J., Billson F.A. Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clinical and Experimental Ophthalmology. 29:2001;188-192.
38. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., Smith L.E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proceedings of the National Academy of Sciences of the United States of America. 92:1995;905-909.
39. Qiao X., Hefti F., Knusel B., Noebels J.L. Selective failure of brain-derived neurotrophic factor mRNA expression in the cerebellum of stargazer a mutant mouse with ataxia. Journal of Neuroscience. 16:1996;640-648.
40. Ranson N.T., Danis R.P., Ciulla T.A., Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. British Journal of Ophthalmology. 86:2002;527-529.
41. Robinson G.S., Pierce E.A., Rook S.L., Foley E., Webb R., Smith L.E. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;4851-4856.
42. Spilsbury K., Garrett K.L., Shen W.Y., Constable I.J., Rakoczy P.E. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. American Journal of Pathology. 157:2000;135-144.
43. Tano Y., Chandler D., Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. American Journal of Ophthalmology. 90:1980;810-816.
44. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Archives of Ophthalmology. 117:1999;1329-1345.
45. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials-TAP Report #2. Archives of Ophthalmology. 119:2001;198-207.
46. Wang Y.S., Friedrichs U., Eichler W., Hoffmann S., Wiedemann P. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Archive for Clinical and Experimental Ophthalmology. 240:2002;42-48.
47. Yi X., Ogata N., Komada M., Yamamoto C., Takahashi K., Omori K., Uyama M. Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Archive for Clinical and Experimental Ophthalmology. 235:1997;313-319.